LRRC47

Summary

LRRC47 (leucine rich repeat containing 47, HGNC:29207) is a protein-coding gene on chromosome 1p36.32, encoding Leucine-rich repeat-containing protein 47 (Q8N1G4).

Enables RNA binding activity. Predicted to be involved in phenylalanyl-tRNA aminoacylation.

Source: NCBI Gene 57470 — RefSeq curated summary.

At a glance

• GWAS associations: 6
• Clinical variants (ClinVar): 81 total
• Druggable target: yes
• MANE Select transcript: NM_020710

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:29207
Approved symbol	LRRC47
Name	leucine rich repeat containing 47
Location	1p36.32
Locus type	gene with protein product
Status	Approved
Aliases	KIAA1185, RP1-286D6.3
Ensembl gene	ENSG00000130764
Ensembl biotype	protein_coding
OMIM	619154
Entrez	57470

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 9 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay

ENST00000378251, ENST00000462356, ENST00000479239, ENST00000855510, ENST00000855511, ENST00000855512, ENST00000931368, ENST00000931369, ENST00000931370, ENST00000931371, ENST00000971585

RefSeq mRNA: 1 — MANE Select: NM_020710 NM_020710

CCDS: CCDS51

Canonical transcript exons

ENST00000378251 — 7 exons

Exon	Start	End
ENSE00000896208	3783996	3784111
ENSE00000896210	3785087	3785203
ENSE00000896213	3786849	3787310
ENSE00001122552	3778559	3781336
ENSE00001476853	3795862	3796498
ENSE00003638046	3782661	3782763
ENSE00003691484	3781512	3781601

Expression profiles

Bgee: expression breadth ubiquitous, 287 present calls, max score 98.55.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 32.3468 / max 189.5829, expressed in 1816 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter ID	TPM avg	Samples expressed
9963	32.3468	1816

Top tissues by expression

288 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
middle temporal gyrus	UBERON:0002771	98.55	gold quality
skeletal muscle tissue of rectus abdominis	UBERON:0004511	97.90	gold quality
endothelial cell	CL:0000115	97.89	gold quality
gluteal muscle	UBERON:0002000	97.70	gold quality
Brodmann (1909) area 23	UBERON:0013554	97.69	gold quality
quadriceps femoris	UBERON:0001377	97.66	gold quality
tibialis anterior	UBERON:0001385	97.66	gold quality
vastus lateralis	UBERON:0001379	97.65	gold quality
gingival epithelium	UBERON:0001949	97.43	gold quality
deltoid	UBERON:0001476	97.13	gold quality
triceps brachii	UBERON:0001509	97.07	gold quality
gingiva	UBERON:0001828	97.03	gold quality
skeletal muscle tissue of biceps brachii	UBERON:0004502	96.89	gold quality
skeletal muscle tissue	UBERON:0001134	96.82	gold quality
gastrocnemius	UBERON:0001388	96.73	gold quality
cerebellar vermis	UBERON:0004720	96.72	gold quality
body of tongue	UBERON:0011876	96.72	gold quality
muscle organ	UBERON:0001630	96.57	gold quality
metanephric glomerulus	UBERON:0004736	96.54	gold quality
palpebral conjunctiva	UBERON:0001812	96.36	gold quality
muscle of leg	UBERON:0001383	96.34	gold quality
muscle tissue	UBERON:0002385	96.24	gold quality
esophagus squamous epithelium	UBERON:0006920	96.24	gold quality
tibia	UBERON:0000979	96.22	gold quality
renal glomerulus	UBERON:0000074	96.19	gold quality
mammalian vulva	UBERON:0000997	96.17	gold quality
biceps brachii	UBERON:0001507	96.17	gold quality
seminal vesicle	UBERON:0000998	96.01	gold quality
tongue	UBERON:0001723	95.97	gold quality
nipple	UBERON:0002030	95.97	gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	yes	8.32

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

43 targeting LRRC47, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-3613-3P	100.00	76.36	7965
HSA-MIR-371B-5P	99.99	75.34	4759
HSA-MIR-373-5P	99.98	75.36	4753
HSA-MIR-616-5P	99.98	75.58	4775
HSA-MIR-548AA	99.96	70.64	3753
HSA-MIR-548AP-3P	99.96	70.64	3753
HSA-MIR-548T-3P	99.96	70.64	3753
HSA-MIR-589-3P	99.91	69.62	2088
HSA-MIR-6780A-5P	99.88	66.69	2776
HSA-MIR-548D-3P	99.87	70.67	4362
HSA-MIR-548BB-3P	99.86	70.58	4354
HSA-MIR-383-3P	99.85	65.84	1359
HSA-MIR-629-3P	99.85	67.99	1875
HSA-MIR-4728-5P	99.85	69.39	4718
HSA-MIR-548AC	99.84	70.77	4351
HSA-MIR-548H-3P	99.84	70.80	4349
HSA-MIR-548Z	99.84	70.80	4349
HSA-MIR-6785-5P	99.82	68.68	4428
HSA-MIR-4713-5P	99.78	67.80	1794
HSA-MIR-1299	99.77	71.24	2389
HSA-MIR-1273H-5P	99.77	66.32	2471
HSA-MIR-2116-3P	99.74	64.32	889
HSA-MIR-30B-3P	99.70	65.76	2325
HSA-MIR-3689A-3P	99.70	65.73	2306
HSA-MIR-3689B-3P	99.70	65.71	2311
HSA-MIR-3689C	99.70	65.71	2311
HSA-MIR-6779-5P	99.70	65.76	2363
HSA-MIR-875-3P	99.63	69.47	2548
HSA-MIR-6134	99.63	65.68	1537
HSA-MIR-7106-5P	99.53	67.47	3574

Cross-species orthologs

4 orthologs

Organism	Symbol	Gene ID
danio_rerio	lrrc47	ENSDARG00000053138
mus_musculus	Lrrc47	ENSMUSG00000029028
rattus_norvegicus	Lrrc47	ENSRNOG00000024796
caenorhabditis_elegans	Y54E10A.6	WBGENE00021828

Paralogs (1): FARSB (ENSG00000116120)

Protein

Protein identifiers

Leucine-rich repeat-containing protein 47 — Q8N1G4 (reviewed: Q8N1G4)

All UniProt accessions (2): Q8N1G4, J3KRP5

RefSeq proteins (1): NP_065761* (*=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR001611	Leu-rich_rpt	Repeat
IPR003591	Leu-rich_rpt_typical-subtyp	Repeat
IPR005146	B3/B4_tRNA-bd	Domain
IPR020825	Phe-tRNA_synthase-like_B3/B4	Homologous_superfamily
IPR025875	Leu-rich_rpt_4	Repeat
IPR032675	LRR_dom_sf	Homologous_superfamily
IPR045060	Phe-tRNA-ligase_IIc_bsu	Family

Pfam: PF12799, PF13855

UniProt features (62 total): strand 20, helix 13, repeat 7, turn 7, modified residue 6, sequence variant 3, region of interest 2, initiator methionine 1, chain 1, coiled-coil region 1, compositionally biased region 1

Structure

Experimental structures (PDB)

5 structures.

PDB	Method	Resolution (Å)
6ZXG	ELECTRON MICROSCOPY	2.6
6ZXE	ELECTRON MICROSCOPY	3
6ZXD	ELECTRON MICROSCOPY	3.2
8XP3	ELECTRON MICROSCOPY	3.4
6ZXF	ELECTRON MICROSCOPY	3.7

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-Q8N1G4-F1	77.50	0.27

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (6): 2, 315, 431, 509, 518, 520

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 67 (showing top): GOBP_AMINO_ACID_ACTIVATION, GOBP_TRNA_METABOLIC_PROCESS, GOBP_TRANSLATION, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, TIEN_INTESTINE_PROBIOTICS_24HR_UP, HAN_SATB1_TARGETS_DN, SENESE_HDAC3_TARGETS_DN, GOMF_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS, chr1p36, KRIEG_KDM3A_TARGETS_NOT_HYPOXIA, GOMF_CATALYTIC_ACTIVITY_ACTING_ON_RNA, GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_TRNA, CEBPZ_TARGET_GENES, DACH1_TARGET_GENES, MAFG_TARGET_GENES

GO Biological Process (1): phenylalanyl-tRNA aminoacylation (GO:0006432)

GO Molecular Function (3): RNA binding (GO:0003723), phenylalanine-tRNA ligase activity (GO:0004826), protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
tRNA aminoacylation for protein translation	1
nucleic acid binding	1
aminoacyl-tRNA ligase activity	1
binding	1

Protein interactions and networks

STRING

2752 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
LRRC47	RIOK1	Q9BRS2	612
LRRC47	EIF1AD	Q8N9N8	549
LRRC47	CCDC27	Q2M243	520
LRRC47	PJA2	O43164	487
LRRC47	C1orf54	Q8WWF1	465
LRRC47	EIF3CL	B5ME19	449
LRRC47	C1orf174	Q8IYL3	447
LRRC47	CEP104	O60308	445
LRRC47	RIOK2	Q9BVS4	440
LRRC47	SPRYD3	Q8NCJ5	412
LRRC47	RBMS2	Q15434	406
LRRC47	XPO1	O14980	404
LRRC47	KCNH2	Q12809	403
LRRC47	MICU2	Q8IYU8	403
LRRC47	OLA1	Q9NTK5	402
LRRC47	CPSF2	Q9P2I0	402

IntAct

70 interactions, top by confidence:

A	B	Type	Score
MED4	MED19	psi-mi:“MI:0914”(association)	0.900
MED20	MED19	psi-mi:“MI:0914”(association)	0.840
CUL4B	COPS2	psi-mi:“MI:0914”(association)	0.790
RIOK1	PRMT5	psi-mi:“MI:0914”(association)	0.710
LRRC47	gag	psi-mi:“MI:0915”(physical association)	0.500
LRRC47	PLOD1	psi-mi:“MI:0915”(physical association)	0.400
	GNAT3	psi-mi:“MI:0915”(physical association)	0.400
JUN		psi-mi:“MI:0914”(association)	0.350
JUN	TPM3	psi-mi:“MI:0914”(association)	0.350
MAPT	C11orf98	psi-mi:“MI:0914”(association)	0.350
MAPT	POTEF	psi-mi:“MI:0914”(association)	0.350
TNFRSF10A	NAP1L4	psi-mi:“MI:0914”(association)	0.350
COPS5	FBLL1	psi-mi:“MI:0914”(association)	0.350
COPS6	DDX3X	psi-mi:“MI:0914”(association)	0.350
LRRK2		psi-mi:“MI:0914”(association)	0.350
TNIP3	RNH1	psi-mi:“MI:0914”(association)	0.350
USP32		psi-mi:“MI:0914”(association)	0.350
USP42	KPNA3	psi-mi:“MI:0914”(association)	0.350
BABAM1	PYCR3	psi-mi:“MI:0914”(association)	0.350
ORF4	CTDNEP1	psi-mi:“MI:0914”(association)	0.350
	SHTN1	psi-mi:“MI:0914”(association)	0.350
	TNFRSF10A	psi-mi:“MI:0914”(association)	0.350
RIN3		psi-mi:“MI:0914”(association)	0.350
PAK4	SNRPE	psi-mi:“MI:0914”(association)	0.350
PAK4	MCM5	psi-mi:“MI:0914”(association)	0.350
MAP1LC3A		psi-mi:“MI:0914”(association)	0.350
MAP1LC3B		psi-mi:“MI:0914”(association)	0.350
MAPT	SHTN1	psi-mi:“MI:0914”(association)	0.350

BioGRID (150): EIF2A (Co-fractionation), LRRC47 (Co-fractionation), LRRC47 (Co-fractionation), LRRC47 (Co-fractionation), LRRC47 (Co-fractionation), NAPRT (Co-fractionation), PSMB6 (Co-fractionation), LRRC47 (Affinity Capture-MS), LRRC47 (Proximity Label-MS), LRRC47 (Affinity Capture-MS), LRRC47 (Affinity Capture-MS), LRRC47 (Proximity Label-MS), LRRC47 (Proximity Label-MS), LRRC47 (Affinity Capture-MS), LRRC47 (Affinity Capture-MS)

ESM2 similar proteins: A0A8P0N4K0, A2AB59, B4F7F3, D3YZU1, D3ZD05, O35681, O75427, O95382, P22455, P22607, P40748, P55144, P70218, Q06418, Q14160, Q1LZH7, Q2PS20, Q32P44, Q495M9, Q4ACU6, Q4H4B6, Q505F5, Q5F488, Q61851, Q63ZY3, Q6P9K8, Q6TLK4, Q6ZUM4, Q7KRY7, Q80T11, Q80U72, Q8BH60, Q8BX02, Q8N1G4, Q8TE68, Q8VC03, Q8VHK1, Q8VHK2, Q8WXD9, Q8WXE0

Diamond homologs: A0B993, A1QZU9, A1RYS1, A2ST82, A3CT77, A4FWS3, A4YIL0, A6UPQ4, A6UWT1, A6VGJ4, A7I615, A9AA58, B0R807, B1L7C0, B2S0L6, B5RM71, B5RPL7, B6YTJ3, B7J278, B8GEX4, B9LU47, C3MJ88, C3MYY0, C3N028, C3N8B1, C3NMS5, C4KJ68, C5A5Z0, C6A237, O26864, O28848, O42849, O73984, P57694, P94283, P95960, Q0W0X4, Q12YP2, Q19713, Q2FLL1

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 96 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

Pathway	Partners	Fold	FDR
SARS-CoV-2 modulates host translation machinery	5	16.2×	8e-04
Influenza Infection	5	12.7×	2e-03
SARS-CoV-1 Infection	6	12.4×	7e-04
Signaling by ROBO receptors	6	10.8×	9e-04
SARS-CoV-2-host interactions	6	10.3×	9e-04
SARS-CoV-2 Infection	7	8.2×	9e-04
Major pathway of rRNA processing in the nucleolus and cytosol	9	8.1×	4e-04
SARS-CoV Infections	7	5.6×	5e-03

GO biological processes:

GO term	Partners	Fold	FDR
cytoplasmic translation	6	12.9×	1e-03
positive regulation of cell growth	5	10.7×	6e-03
positive regulation of canonical Wnt signaling pathway	5	9.0×	1e-02

Disease & clinical

Clinical variants and AI predictions

ClinVar

81 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	65
Likely benign	1
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1343 predictions. Top by Δscore:

Variant	Effect	Δscore
1:3781600:ACC:A	acceptor_loss	1.0000
1:3781601:CCT:C	acceptor_gain	1.0000
1:3781602:C:CC	acceptor_gain	1.0000
1:3781602:C:T	acceptor_gain	1.0000
1:3781603:T:C	acceptor_gain	1.0000
1:3781603:T:TC	acceptor_gain	1.0000
1:3782656:CCTA:C	donor_loss	1.0000
1:3782657:CTACC:C	donor_loss	1.0000
1:3782660:C:A	donor_loss	1.0000
1:3782673:A:AC	donor_gain	1.0000
1:3782674:C:CC	donor_gain	1.0000
1:3782759:GGTAT:G	acceptor_gain	1.0000
1:3782760:GTAT:G	acceptor_gain	1.0000
1:3782761:TAT:T	acceptor_gain	1.0000
1:3782762:AT:A	acceptor_gain	1.0000
1:3782763:TCTG:T	acceptor_loss	1.0000
1:3782764:C:CA	acceptor_loss	1.0000
1:3782764:C:CC	acceptor_gain	1.0000
1:3782765:T:A	acceptor_loss	1.0000
1:3782766:G:C	acceptor_gain	1.0000
1:3784108:CAAT:C	acceptor_gain	1.0000
1:3784112:C:CC	acceptor_gain	1.0000
1:3787064:T:TA	donor_gain	1.0000
1:3787070:C:CA	donor_gain	1.0000
1:3787073:T:TA	donor_gain	1.0000
1:3787079:T:TA	donor_gain	1.0000
1:3787093:T:TA	donor_gain	1.0000
1:3787160:C:CA	donor_gain	1.0000
1:3787306:AACGT:A	acceptor_gain	1.0000
1:3787307:ACGT:A	acceptor_gain	1.0000

AlphaMissense

3707 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
1:3781560:A:C	S485R	0.998
1:3781560:A:T	S485R	0.998
1:3781562:T:G	S485R	0.998
1:3787290:G:C	N212K	0.998
1:3787290:G:T	N212K	0.998
1:3795910:G:C	N189K	0.998
1:3795910:G:T	N189K	0.998
1:3795988:A:C	N163K	0.998
1:3795988:A:T	N163K	0.998
1:3796150:G:C	N109K	0.998
1:3796150:G:T	N109K	0.998
1:3796151:T:A	N109I	0.998
1:3796313:A:G	L55S	0.998
1:3781144:A:C	Y566D	0.997
1:3781539:G:C	C492W	0.997
1:3795866:A:T	L204H	0.997
1:3796060:G:C	N139K	0.997
1:3796060:G:T	N139K	0.997
1:3796061:T:A	N139I	0.997
1:3796175:A:T	L101H	0.997
1:3796222:G:C	N85K	0.997
1:3796222:G:T	N85K	0.997
1:3796238:A:T	L80H	0.997
1:3781540:C:T	C492Y	0.996
1:3785163:G:T	A373D	0.996
1:3787221:G:C	N235K	0.996
1:3787221:G:T	N235K	0.996
1:3787291:T:A	N212I	0.996
1:3795989:T:A	N163I	0.996
1:3796062:T:C	N139D	0.996

dbSNP variants (sampled 300 via entrez): RS1000010436 (1:3784824 C>T), RS1000388489 (1:3794820 C>G), RS1000488149 (1:3789941 G>A), RS1000515827 (1:3790105 G>A), RS1000625061 (1:3786066 C>T), RS1000671680 (1:3781231 T>C), RS1000915190 (1:3795211 T>C), RS1000916168 (1:3780943 T>G), RS1000960846 (1:3785781 A>G), RS1001101341 (1:3786245 C>T), RS1001566744 (1:3782182 A>G), RS1001819343 (1:3780719 C>T), RS1001985844 (1:3796662 C>G,T), RS1002032431 (1:3784909 C>A,T), RS1002094263 (1:3791171 G>A,C,T)

Disease associations

OMIM: gene MIM:619154 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

6 associations (top):

Study	Trait	p-value
GCST001524_16	Visceral adipose tissue/subcutaneous adipose tissue ratio	2.000000e-06
GCST001525_13	Visceral fat	2.000000e-06
GCST001525_2	Visceral fat	2.000000e-06
GCST002041_1	Blood trace element (Cu levels)	5.000000e-10
GCST004621_2	Red cell distribution width	7.000000e-21
GCST90002383_142	Hematocrit	9.000000e-10

EFO canonical traits (4, from GWAS)

EFO ID	Trait name
EFO:0004767	visceral:subcutaneous adipose tissue ratio
EFO:0005267	serum copper measurement
EFO:0009188	Red cell distribution width
EFO:0004348	hematocrit

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6066357 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChembl	Type	Value	Unit	Molecule
8.04	Kd	9.132	nM	CHEMBL5653589
8.04	ED50	9.132	nM	CHEMBL5653589
7.68	Kd	20.68	nM	CHEMBL3752910
7.68	ED50	20.68	nM	CHEMBL3752910

PubChem BioAssay actives

2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

Compound	Assay	Type	Value	Unit
4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide	2148666: Binding affinity to human LRRC47 incubated for 45 mins by Kinobead based pull down assay	kd	0.0091	uM
4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide	2148666: Binding affinity to human LRRC47 incubated for 45 mins by Kinobead based pull down assay	kd	0.0207	uM

CTD chemical–gene interactions

48 total (human), top 30 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Benzo(a)pyrene	affects methylation, decreases expression	2
aristolochic acid I	increases expression	1
FR900359	affects phosphorylation	1
bisphenol A	increases expression	1
pyrogallol 1,3-dimethyl ether	affects cotreatment, affects localization, decreases expression	1
sodium arsenite	affects cotreatment, increases abundance, increases expression	1
cobaltous chloride	increases expression	1
perfluorooctanoic acid	decreases expression	1
manganese chloride	affects cotreatment, increases abundance, increases expression	1
coumarin	affects phosphorylation	1
di-n-butylphosphoric acid	affects expression	1
perfluorooctane sulfonic acid	decreases expression	1
CGP 52608	affects binding, increases reaction	1
perfluoro-n-nonanoic acid	decreases expression	1
perfluorohexanesulfonic acid	decreases expression	1
bisphenol S	increases expression	1
bisphenol AF	increases expression	1
Resveratrol	affects cotreatment, increases expression	1
Temozolomide	increases expression	1
Sunitinib	increases expression	1
Adenine	decreases expression	1
Air Pollutants	decreases expression, increases abundance	1
Arsenic	affects cotreatment, increases abundance, increases expression	1
Atrazine	decreases expression	1
Cadmium	decreases expression	1
Caffeine	increases phosphorylation	1
Cisplatin	decreases expression	1
Colchicine	decreases expression	1
Doxorubicin	increases expression	1
Enzyme Inhibitors	decreases activity, increases O-linked glycosylation	1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay ID	Type	Description	Source paper
CHEMBL5651708	Binding	Binding affinity to human LRRC47 incubated for 45 mins by Kinobead based pull down assay	NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.